Hyderabad : 04 Jan 21 Away from the hustle-bustle of Hyderabad, 51-year-old Dr Krishna Ella is busy working at his lab in the genome valley of Hyderabad. For him, it is always ‘India First’.The company has got global attention after the Government of India (GoI) granted the emergency use permission to the vaccine against the coronavirus disease — Covaxin.Dr Krishna Ella, the founder and chairman of Bharat Biotech, has hailed the decision of DCGI to approve Covaxin for emergency restricted use and termed it as a giant leap for innovation and novel product development in India.
